Convergent Evolution Driven by Rifampin Exacerbates the Global Burden of Drug-Resistant Staphylococcus aureus.

ABSTRACT: Mutations in the beta-subunit of bacterial RNA polymerase (RpoB) cause resistance to rifampin (Rif^r), a critical antibiotic for treatment of multidrug-resistant Staphylococcus aureus. In vitro studies have shown that RpoB mutations confer decreased susceptibility to other antibiotics, but the clinical relevance is unknown. Here, by analyzing 7,099 S. aureus genomes, we demonstrate that the most prevalent RpoB mutations promote clinically relevant phenotypic plasticity resulting in the emergence of stable S. aureus lineages, associated with increased risk of therapeutic failure through generation of small-colony variants (SCVs) and coresistance to last-line antimicrobial agents. We found eight RpoB mutations that accounted for 93% (469/505) of the tota

SUBMITTER: Guerillot R 

PROVIDER: S-EPMC5784246 | biostudies-literature | 2018 Jan-Feb

REPOSITORIES: biostudies-literature